Combining exercise with GLP-1 RA liraglutide results in significant weight loss while preserving bone health in adults with obesity.
Neumora’s big neuroscience plans head toward the Nasdaq in second PhIII biotech IPO pitch in 24 hours
The largely dormant biotech IPO market started sizzling Friday, with two Phase III drug developers sending in their pitches for Nasdaq debuts this fall. After